The GSH levels of hES-MSCs isolated using FreSHtracer or cultured at different cell densities were monitored for 1 h following treatment with indicated amounts of diamide
Wegovy (semaglutide) is a GLP-1 receptor agonist licensed in the UK for weight management in adults with obesity or overweight with weight-related comorbidities
In the context of EMS, impaired mitophagy has significant pathological implications, resulting in the accumulation of dysfunctional mitochondria and elevated levels of ROS
Davioud-Charvet E, Delarue S, Biot C, Schwobel B, Boehme CC, Mussigbrodt A, Maes L, Sergheraert C, Grellier P, Schirmer RH and Becker K
In comparison, an emerging treatment with potential therapeutic application, in the form of a pentadecapeptide known as BPC 157 (body protection compound), appears to be somewhat unrestricted by the limitations seen in previous therapies